• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Tempus AI Inc.

    11/12/24 5:00:02 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology
    Get the next $TEM alert in real time by email
    SC 13G 1 lefkofsky_-_13g_-_9.30.2.htm SC 13G SC 13G

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

    Tempus AI, Inc.

    (Name of Issuer)

    Class A Common Stock, $0.0001 Par Value Per Share

    (Title of Class of Securities)

    88023B103

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of This Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


    CUSIP No. 88023B103

     

    Page 2 of 7 Pages

     

     

     

     

     

     

     

    1.

    Name of Reporting Persons

    Eric Paul Lefkofsky

    2.

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒(1)

    3.

    SEC USE ONLY

    4.

    Citizenship or Place of Organization

    United States

     

     

     

     

     

     

     

     

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

    5.

    Sole Voting Power

    5,962,227(2)

    6.

    Shared Voting Power

    48,455,700(3)

    7.

    Sole Dispositive Power

    5,962,227(2)

    8.

    Shared Dispositive Power

    48,455,700(3)

     

     

     

     

     

     

     

     

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    54,417,927(2)(3)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

    ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    34.3% of Class A Common Stock(4) (34.3% of combined Common Stock)(5)

    12.

    Type of Reporting Person (See Instructions)

    IN

    (1)

    This Schedule 13G is filed by Eric Paul Lefkofsky (“Mr. Lefkofsky”), Blue Media, LLC (“Blue Media”) and Gray Media, LLC (“Gray Media” and together with Mr. Lefkofsky and Blue Media, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

     

    (2)

    Consists of: (i) 1,455,329 shares of the Issuer’s Class A Common Stock and (ii) 4,506,898 shares of the Issuer’s Class A Common Stock issuable upon the vesting of restricted stock units within 60 days of September 30, 2024.

     


    (3)

    Consists of: (i) 206 shares of the Issuer’s Class A Common Stock held by Black Media, LLC (“Black Media”), (ii) 27,619,558 shares of the Issuer’s Class A Common Stock held by Blue Media, (iii) 9,607,283 shares of the Issuer’s Class A Common Stock held by Gray Media, (iv) 145,966 shares of the Issuer’s Class A Common Stock held by Innovation Group Investors LP Series 1B (“Series 1B”), (v) 4,060,547 shares of the Issuer’s Class A Common Stock held by Innovation Group Investors LP 2011 Series (“2011 Series”), (vi) 332,131 shares of the Issuer’s Class A Common Stock held by Lefkofsky Family Foundation DTD 9/5/06 Eric Lefkofsky TTEE (the “Foundation”), (vii) 1,397,589 shares of the Issuer’s Class A Common Stock held by Lightbank Global LLC (“Lightbank Global”), (viii) 248,631 shares of the Issuer’s Class A Common Stock held by Lightbank Investments 1B LLC (“Lightbank Investments”), (ix) 178,485 shares of the Issuer’s Class A Common Stock issuable upon conversion of 178,485 shares of the Issuer’s Class B Common Stock held by Black Media, (x) 3,972,878 shares of the Issuer’s Class A Common Stock issuable upon conversion of 3,972,878 shares of the Issuer’s Class B Common Stock held by Blue Media and (xi) 892,426 shares of the Issuer’s Class A Common Stock issuable upon conversion of 892,426 shares of the Issuer’s Class B Common Stock held by 2011 Series. Mr. Lefkofsky is the sole manager of each of Black Media, Blue Media, Gray Media, Series 1B, 2011 Series, Lightbank Global and Lightbank Investments. Mr. Lefkofsky and his wife, Elizabeth Lefkofsky, serve as trustees of the Foundation. Mr. Lefkofsky holds shared voting and dispositive power of the securities reported herein.

     

    (4)

    This percentage is calculated based upon the sum of (i) 149,274,923 shares of the Issuer’s Class A Common Stock outstanding as of August 6, 2024 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2024 (the “Quarterly Report”), (ii) Class A Common Stock issuable upon conversion of 5,043,789 shares of Class B Common Stock beneficially owned by Mr. Lefkofsky, which are treated as converted into Class A Common Stock only for the purpose of computing the Class A Common Stock beneficial ownership percentage of Mr. Lefkofsky and (iii) 4,506,898 shares of the Issuer’s Class A Common Stock issuable upon the vesting of restricted stock units within 60 days of September 30, 2024.

     

    (5)

    This percentage is calculated based upon the sum of (i) a total of 154,318,712 shares of Common Stock (149,274,923 shares of the Issuer’s Class A Common Stock and 5,043,789 shares of the Issuer’s Class B Common Stock) outstanding as of August 6, 2024, as reported in the Quarterly Report and (ii) 4,506,898 shares of the Issuer’s Class A Common Stock issuable upon the vesting of restricted stock units within 60 days of September 30, 2024.

     

     


    CUSIP No. 88023B103

     

    Page 3 of 7 Pages

     

     

     

     

     

     

     

    1.

    Name of Reporting Persons

    Blue Media, LLC

    2.

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒(1)

    3.

    SEC USE ONLY

    4.

    Citizenship or Place of Organization

    Delaware

     

     

     

     

     

     

     

     

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    31,592,436(2)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    31,592,436(2)

     

     

     

     

     

     

     

     

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    31,592,436(2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

    ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    20.6% of Class A Common Stock(3) (20.5% of combined Common Stock)(4)

    12.

    Type of Reporting Person (See Instructions)

    OO

    (1)

    This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)

    Consists of: (i) 27,619,558 shares of the Issuer’s Class A Common Stock held by Blue Media and (ii) 3,972,878 shares of the Issuer’s Class A Common Stock issuable upon conversion of 3,972,878 shares of the Issuer’s Class B Common Stock held by Blue Media. Mr. Lefkofsky is the sole manager of Blue Media and shares voting and dispositive power of the securities reported herein.

     

    (3)

    This percentage is calculated based upon the sum of (i) 149,274,923 shares of the Issuer’s Class A Common Stock outstanding as of August 6, 2024 as reported in the Quarterly Report and (ii) Class A Common Stock issuable upon conversion of 3,972,878 shares of Class B Common Stock beneficially owned by Blue Media, which are treated as converted into Class A Common Stock only for the purpose of computing the Class A Common Stock beneficial ownership percentage of Blue Media.

     

    (4)

    This percentage is calculated based upon a total of 154,318,712 shares of Common Stock (149,274,923 shares of the Issuer’s Class A Common Stock and 5,043,789 shares of the Issuer’s Class B Common Stock) outstanding as of August 6, 2024, as reported in the Quarterly Report.

     


    CUSIP No. 88023B103

     

    Page 4 of 7 Pages

     

     

     

     

     

     

     

    1.

    Name of Reporting Persons

    Gray Media, LLC

    2.

    Check the Appropriate Box if a Member of a Group (See Instructions)

    (a) ☐ (b) ☒(1)

    3.

    SEC USE ONLY

    4.

    Citizenship or Place of Organization

    Delaware

     

     

     

     

     

     

     

     

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With:

    5.

    Sole Voting Power

    0

    6.

    Shared Voting Power

    9,607,283(2)

    7.

    Sole Dispositive Power

    0

    8.

    Shared Dispositive Power

    9,607,283(2)

     

     

     

     

     

     

     

     

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    9,607,283(2)

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

    ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    6.4% of Class A Common Stock (6.2% of combined Common Stock)(3)

    12.

    Type of Reporting Person (See Instructions)

    OO

    (1)

    This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

     

    (2)

    Mr. Lefkofsky is the sole manager of Gray Media and shares voting and dispositive power of the securities reported herein.

     

    (3)

    Calculation of the percentage of Class A Common Stock beneficially owned is based upon 149,274,923 shares of the Issuer’s Class A Common Stock outstanding as of August 6, 2024, as reported in the Quarterly Report. Calculation of the percentage of combined Common Stock beneficially owned is based upon a total of 154,318,712 shares of Common Stock (149,274,923 shares of the Issuer’s Class A Common Stock and 5,043,789 shares of the Issuer’s Class B Common Stock) outstanding as of August 6, 2024, as reported in the Quarterly Report.

     

     

     

     

     

     

     

     

     

     


    CUSIP No. 88023B103

     

    Page 5 of 7 Pages

    Item 1(a)

    Name of Issuer

    Tempus AI, Inc. (the “Issuer”)

    Item 1(b)

    Address of Issuer’s Principal Executive Offices

    600 West Chicago Avenue, Suite 510
    Chicago, IL 60654

    Item 2(a)

    Name of Person Filing

    Eric Paul Lefkofsky (“Mr. Lefkofsky”)

    Blue Media, LLC (“Blue Media”)

    Gray Media, LLC (“Gray Media” and together with Mr. Lefkofsky and Blue Media, the “Reporting Persons”)

    Item 2(b)

    Address of Principal Business Office or, if none, Residence

    c/o Tempus AI, Inc.
    600 West Chicago Avenue, Suite 510
    Chicago, IL 60654

    Item 2(c)

    Citizenship

    Individuals: Mr. Lefkofsky - United States

    Entities: Blue Media - Delaware

    Gray Media - Delaware

    Item 2(d)

    Title of Class of Securities

    Class A Common Stock, $0.0001 par value per share

    Item 2(e)

    CUSIP Number

    88023B103

    Item 3

    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    Not applicable.

    Item 4

    Ownership

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1:

    (a)

    Amount beneficially owned: See responses to Item 9 on the attached cover pages.

     

    (b)

    Percent of class: See responses to Item 11 on the attached cover pages.

     

     

     


    CUSIP No. 88023B103

     

    Page 6 of 7 Pages

    (c)

    Number of shares as to which the person has:

    (i)

    Sole power to vote or to direct the vote: See responses to Item 5 on the attached cover pages.

    (ii)

    Shared power to vote or to direct the vote: See responses to Item 6 on the attached cover pages.

    (iii)

    Sole power to dispose or to direct the disposition of: See responses to Item 7 on the attached cover pages.

    (iv)

    Shared power to dispose or to direct the disposition of: See responses to Item 8 on the attached cover pages.

    Item 5

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ☐

    Item 6

    Ownership of More than Five Percent of Another Person

    Not applicable.

    Item 7

    Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company

    Not applicable.

    Item 8

    Identification and Classification of Members of the Group

    Not applicable.

    Item 9

    Notice of Dissolution of Group

    Not applicable.

    Item 10

    Certification

    Not applicable.


     

     

     

     

     

    CUSIP No. 88023B103

     

    Page 7 of 7 Pages

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    Dated: November 12, 2024

     

     

     

    /s/ Eric Paul Lefkofsky

    Eric Paul Lefkofsky

     

    BLUE MEDIA, LLC

     

     

    By:

    /s/ Eric Paul Lefkofsky

    Name:

    Eric Paul Lefkofsky

    Title:

    Manager

     

    GRAY MEDIA, LLC

     

     

    By:

    /s/ Eric Paul Lefkofsky

    Name:

    Eric Paul Lefkofsky

    Title:

    Manager

     

     

     

    EXHIBITS

    A:

    Joint Filing Agreement

     


    Exhibit A

    JOINT FILING AGREEMENT

    In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A Common Stock of Tempus AI, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

    IN WITNESS WHEREOF, the undersigned have executed this Joint Filing Agreement as of November 12, 2024.

     

     

    /s/ Eric Paul Lefkofsky

     

    Eric Paul Lefkofsky

     

     

    BLUE MEDIA, LLC

     

    By:

    /s/ Eric Paul Lefkofsky

    Name:

    Eric Paul Lefkofsky

    Title:

    Manager

     

     

     

     

    GRAY MEDIA, LLC

     

    By:

    /s/ Eric Paul Lefkofsky

    Name:

    Eric Paul Lefkofsky

    Title:

    Manager

     

     

     

     

     

     


    Get the next $TEM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TEM

    DatePrice TargetRatingAnalyst
    2/19/2026$100.00Outperform
    Mizuho
    2/17/2026$59.00Outperform
    Robert W. Baird
    12/2/2025$85.00Overweight
    Morgan Stanley
    10/21/2025$88.00Buy → Hold
    TD Cowen
    10/20/2025$110.00Buy
    Canaccord Genuity
    9/2/2025$90.00Buy
    H.C. Wainwright
    4/21/2025$60.00Buy
    BTIG Research
    2/25/2025$50.00 → $55.00Overweight → Neutral
    Analyst
    More analyst ratings

    $TEM
    SEC Filings

    View All

    SEC Form 144 filed by Tempus AI Inc.

    144 - Tempus AI, Inc. (0001717115) (Subject)

    3/2/26 4:38:26 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-8 filed by Tempus AI Inc.

    S-8 - Tempus AI, Inc. (0001717115) (Filer)

    2/24/26 4:58:11 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    SEC Form 10-K filed by Tempus AI Inc.

    10-K - Tempus AI, Inc. (0001717115) (Filer)

    2/24/26 4:06:41 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes

    Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 3, 2026 /CNW/ -- USANewsGroup.com News Commentary -- AI is making its way through the halls of our entire medical system, and the implementation is accelerating at a great pace. The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR[1]. Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand cardiac platforms that prove economic value alongside clinical accuracy[2]. Companies like VentriPoint Diagnostics (TSXV:VPT) (OTCPK: VPTDF), Butterfly Network (NYSE:BFLY), Tempus AI (NASDAQ:TEM), RadNet (NASDAQ:RDNT), and GE HealthCare (NASDAQ:GEHC) are conv

    3/3/26 12:19:00 PM ET
    $BFLY
    $GEHC
    $RDNT
    Medical Electronics
    Health Care
    Medical Specialities
    Computer Software: Programming Data Processing

    Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

    Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada, today announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomarkers and supporting Merck's oncology and potentially broader therapeutic portfolios. "This collaboration builds on our existing relationship and reflects our shared commitment to harnessing the power of multimodal datasets with AI to deliver better options for patients," said Ryan Fukushima, CEO, Data & Apps at Tempus. "We've spent years configuring our Lens Platform to seamlessly lever

    3/3/26 8:30:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

    Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that it will participate in the Morgan Stanley Technology, Media, and Telecom Conference on Tuesday, March 3 in San Francisco. Eric Lefkofsky, Tempus Founder and CEO, will participate in a fireside chat at 9:15 AM PST. The live webcast may be accessed directly using the following link: https://event.webcasts.com/starthere.jsp?ei=1753938&tp_key=e25fc24c17&tp_special=8. A recording will be made available on the Events page of Tempus' Investor Relations website. About Tempus Tempus is a technology company advancing precision medicine through the practical applicati

    2/26/26 8:30:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Tempus Ai, Inc. bought $2,739,181 worth of shares (320,267 units at $8.55), increasing direct ownership by 3% to 13,039,067 units (SEC Form 4)

    4 - Tempus AI, Inc. (0001717115) (Reporting)

    2/13/26 5:24:46 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Large owner Tempus Ai, Inc. exercised 9,218,800 in-the-money shares at a strike of $2.00 and bought $17,745,000 worth of shares (3,500,000 units at $5.07) (SEC Form 4)

    4 - Tempus AI, Inc. (0001717115) (Reporting)

    8/20/24 4:17:55 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Tempus AI with a new price target

    Mizuho initiated coverage of Tempus AI with a rating of Outperform and set a new price target of $100.00

    2/19/26 7:52:33 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Robert W. Baird initiated coverage on Tempus AI with a new price target

    Robert W. Baird initiated coverage of Tempus AI with a rating of Outperform and set a new price target of $59.00

    2/17/26 8:19:06 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Morgan Stanley resumed coverage on Tempus AI with a new price target

    Morgan Stanley resumed coverage of Tempus AI with a rating of Overweight and set a new price target of $85.00

    12/2/25 8:35:17 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Epstein David R sold $12,672 worth of shares (250 units at $50.69), decreasing direct ownership by 0.96% to 25,801 units (SEC Form 4)

    4 - Tempus AI, Inc. (0001717115) (Issuer)

    3/4/26 4:30:27 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Rogers James William sold $578,576 worth of shares (11,414 units at $50.69), decreasing direct ownership by 8% to 127,248 units (SEC Form 4)

    4 - Tempus AI, Inc. (0001717115) (Issuer)

    3/4/26 4:30:25 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    New insider Schoenherr Thomas Edward claimed ownership of 94,967 shares (SEC Form 3)

    3 - Tempus AI, Inc. (0001717115) (Issuer)

    2/25/26 7:12:07 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Leadership Updates

    Live Leadership Updates

    View All

    FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc.

    Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis® LCS Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway already in place to support expansion Active discussions underway to establish key clinical partnerships to support broad access across U.S. lung cancer screening programs Webcasts will be held on February 26, 2026, to discuss the Company's recent achievements and upcoming milestones for eyonis® LCS deployment in the U.S. Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218440005/en/Oran Muduroglu Appointed Presi

    2/18/26 11:45:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025

    Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2025. The meeting is taking place November 5 - 9 at the Gaylord National Convention Center in National Harbor, Maryland. "We're excited to join the oncology community at this year's meeting and highlight our latest research and progress in advancing the immuno-oncology field," said Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus. "Our latest findings demonstrate the potential of integrated, data-driven approaches to refine biomarkers, im

    11/5/25 8:30:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Financials

    Live finance-specific insights

    View All

    Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24

    Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2025 on Tuesday, February 24, 2026. The company will hold the earnings conference call at 4:30 pm ET. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 4652845 United States - New York: (646) 307-1963 USA & Canada - Toll-Free: (800) 715-9871 Live Webcast: https://edge.media-

    2/10/26 8:30:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Tempus to Report Third Quarter 2025 Financial Results on November 4

    Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter of 2025 on November 4, 2025. The company will hold the earnings conference call at 4:30 pm ET. The call will feature Tempus Founder and CEO, Eric Lefkofsky, and Chief Financial Officer, Jim Rogers. The live audio webcast will be accessible through the events page of Tempus' Investor Relations website. Alternatively, the call can be accessed via the following: Conference ID: 5436492 USA & Canada: Toll-Free (800) 715-9871 United States: Toll (646) 307-1963 Live Webcast: https://edge.media-server.com/mmc/p/vg3azega A

    10/21/25 8:30:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Tempus Announces the Acquisition of Paige

    Paige's strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acquisition of Paige, an AI company specializing in digital pathology. The acquisition allows Tempus to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology with an industry leading technology portfolio. Founded in 2017, Paige has developed and deployed several AI applications, including the first FDA-cleared AI application in pathology, allowin

    8/22/25 9:20:00 AM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    $TEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Tempus AI Inc.

    SC 13G - Tempus AI, Inc. (0001717115) (Subject)

    11/12/24 5:00:02 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Tempus AI Inc.

    SC 13G - Tempus AI, Inc. (0001717115) (Subject)

    11/12/24 4:30:28 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13D/A filed by Tempus AI Inc.

    SC 13D/A - Tempus AI, Inc. (0001717115) (Filed by)

    8/20/24 4:27:51 PM ET
    $TEM
    Computer Software: Programming Data Processing
    Technology